Kancera
Biotechnology Research
Solna, Stockholms Län, Se
8 employees
FIRST
- Employees
- 8
- Contacts
- 2
- Emails
- 2
Kancera Overview
- Headquarters
- Solna, Stockholms Län, Se
- Website
- kancera.se
- Industry
- Biotechnology Research
- Employees
- 8
- Founded
- 2010
- Stock Symbol
- FIRST
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Kancera
Kancera is a clinical stage biotech developing a new class of small molecule drugs with an immune cell modulating mode-of-action with focus on cardiovascular diseases. The lead program KAND567 is in clinical phase II-stage and is aiming to prevent reperfusion injury that may occur in connection with percutaneous coronary intervention in acute myocardial infarction. The stock is traded on the Nasdaq First North Premier Growth Market.
Kancera Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Kancera Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Johan Schultz | Greater Stockholm Metropolitan Area, Sweden |
Email
|
|
| Robert Edfors Md, Phd, Fesc | Chief Medical Officer | Stockholm, Stockholm County, Sweden |
View
|
| Maria Sahlberg |
View
|
||
| Thomas Olin | Solna, Stockholm County, Sweden |
Email
|
Employees by Management Level
Executive
1 profile
Director
1 profile
Individual contributor
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| Sales | 1 | 1 | 0 |
| Executive | 1 | 1 | 0 |
Compare Similar Companies to Kancera
Calliditas Therapeutics
Pharmaceutical Manufacturing
BioArctic
Biotechnology Research
Anocca
Biotechnology Research
Oncopeptides AB (publ)
Pharmaceutical Manufacturing
Pelago Bioscience AB
Biotechnology Research
Medivir AB
Pharmaceutical Manufacturing
Mendus AB
Biotechnology Research
Alligator Bioscience AB
Biotechnology Research
AlzeCure Pharma
Biotechnology Research
Alzinova AB
Biotechnology